A significant breakthrough in cancer research is emerging with the use of VHH fragments to re-engage dysfunctional p53. This essential cancer inhibitor protein is frequently inactivated in various kinds of cancer, https://esocialmall.com/story7461703/nanobodies-restore-p53-new-potential-hope-for-tumor-management